Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Application of Novel DOPA-containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials.

MacPhee RA, Tailly T, Vangala SK, Koepsel J, Brennan L, Cadieux PA, Burton J, Dalsin J, Razvi H, Wattengel C.

J Endourol. 2019 May 29. doi: 10.1089/end.2019.0009. [Epub ahead of print]

PMID:
31140304
2.

Efficacy of Dentaq® Oral and ENT Health Probiotic Complex on Clinical Parameters of Gingivitis in Patients Undergoing Fixed Orthodontic Treatment: A Pilot Study.

Kolip D, Yılmaz N, Gökkaya B, Kulan P, Kargul B, MacDonald KW, Cadieux PA, Burton JP, James KM.

J Clin Dent. 2016 Sep;27(3):66-70.

PMID:
28390199
3.

Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant.

James KM, MacDonald KW, Chanyi RM, Cadieux PA, Burton JP.

J Med Microbiol. 2016 Apr;65(4):328-36. doi: 10.1099/jmm.0.000226. Epub 2016 Feb 3.

PMID:
26847045
4.

Ureteral stent technology: Drug-eluting stents and stent coatings.

Yang L, Whiteside S, Cadieux PA, Denstedt JD.

Asian J Urol. 2015 Oct;2(4):194-201. doi: 10.1016/j.ajur.2015.08.006. Epub 2015 Sep 21. Review.

5.

The Effect of Renal Cysts on the Fragmentation of Renal Stones During Shockwave Lithotripsy: A Comparative In Vitro Study.

Alenezi H, Olvera-Posada D, Cadieux PA, Denstedt JD, Razvi H.

J Endourol. 2016 May;30 Suppl 1:S12-7. doi: 10.1089/end.2015.0253. Epub 2015 Oct 9.

PMID:
26414112
6.

The influence of urinary pH on antibiotic efficacy against bacterial uropathogens.

Yang L, Wang K, Li H, Denstedt JD, Cadieux PA.

Urology. 2014 Sep;84(3):731.e1-7. doi: 10.1016/j.urology.2014.04.048.

PMID:
25168568
7.

Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.

Goneau LW, Yeoh NS, MacDonald KW, Cadieux PA, Burton JP, Razvi H, Reid G.

Antimicrob Agents Chemother. 2014;58(4):2089-97. doi: 10.1128/AAC.02552-13. Epub 2014 Jan 21.

8.

Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls.

Fahmy N, Sener A, Sabbisetti V, Nott L, Lang RM, Welk BK, Méndez-Probst CE, MacPhee RA, VanEerdewijk S, Cadieux PA, Bonventre JV, Razvi H.

J Endourol. 2013 Dec;27(12):1455-62. doi: 10.1089/end.2013.0188. Epub 2013 Nov 1.

9.

Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.

Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K, Hale JD, Tagg J, Reid G, Gloor GB, Cadieux PA.

PLoS One. 2013 Jun 13;8(6):e65991. doi: 10.1371/journal.pone.0065991. Print 2013.

10.

The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial.

Mendez-Probst CE, Goneau LW, MacDonald KW, Nott L, Seney S, Elwood CN, Lange D, Chew BH, Denstedt JD, Cadieux PA.

BJU Int. 2012 Sep;110(5):749-54. doi: 10.1111/j.1464-410X.2011.10903.x. Epub 2012 Feb 7.

11.

Effects of subinhibitory concentrations of ciprofloxacin on Staphylococcus saprophyticus adherence and virulence in urinary tract infections.

Erdeljan P, MacDonald KW, Goneau LW, Bevan T, Carriveau R, Razvi H, Denstedt JD, Cadieux PA.

J Endourol. 2012 Jan;26(1):32-7. doi: 10.1089/end.2011.0183. Epub 2011 Sep 9.

PMID:
21905846
12.

Beneficial microbes for the oral cavity: time to harness the oral streptococci?

Burton JP, Wescombe PA, Cadieux PA, Tagg JR.

Benef Microbes. 2011 Jun;2(2):93-101. doi: 10.3920/BM2011.0002. Review.

PMID:
21840808
13.

Third prize: the impact of fluid environment manipulation on shockwave lithotripsy artificial calculi fragmentation rates.

Méndez-Probst CE, Fernadez A, Erdeljan P, Vanjecek M, Cadieux PA, Razvi H.

J Endourol. 2011 Mar;25(3):397-401. doi: 10.1089/end.2010.0242.

PMID:
21401394
14.

Ordnance gelatine as an in vitro tissue simulation scaffold for extracorporeal shock wave lithotripsy.

Mendez-Probst CE, Vanjecek M, Razvi H, Cadieux PA.

Urol Res. 2010 Dec;38(6):497-503. doi: 10.1007/s00240-010-0329-7. Epub 2010 Oct 22.

PMID:
20967432
15.

Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.

Cadieux PA, Burton J, Devillard E, Reid G.

J Physiol Pharmacol. 2009 Dec;60 Suppl 6:13-8.

PMID:
20224146
16.

Novel in vitro model for studying ureteric stent-induced cell injury.

Elwood CN, Lange D, Nadeau R, Seney S, Summers K, Chew BH, Denstedt JD, Cadieux PA.

BJU Int. 2010 May;105(9):1318-23. doi: 10.1111/j.1464-410X.2009.09001.x. Epub 2009 Nov 3.

17.

Anti-adhesive coating and clearance of device associated uropathogenic Escherichia coli cystitis.

Pechey A, Elwood CN, Wignall GR, Dalsin JL, Lee BP, Vanjecek M, Welch I, Ko R, Razvi H, Cadieux PA.

J Urol. 2009 Oct;182(4):1628-36. doi: 10.1016/j.juro.2009.06.008. Epub 2009 Aug 15.

18.

Use of triclosan-eluting ureteral stents in patients with long-term stents.

Cadieux PA, Chew BH, Nott L, Seney S, Elwood CN, Wignall GR, Goneau LW, Denstedt JD.

J Endourol. 2009 Jul;23(7):1187-94. doi: 10.1089/end.2008.0437.

PMID:
19538062
19.

Eliminating biofilm from ureteral stents: the Holy Grail.

Denstedt JD, Cadieux PA.

Curr Opin Urol. 2009 Mar;19(2):205-10. doi: 10.1097/MOU.0b013e328323d6d2. Review.

PMID:
19188775
20.

The effects of triclosan on uropathogen susceptibility to clinically relevant antibiotics.

Wignall GR, Goneau LW, Chew BH, Denstedt JD, Cadieux PA.

J Endourol. 2008 Oct;22(10):2349-56. doi: 10.1089/end.2008.9705.

PMID:
18937596
21.

First prize: Novel uropathogen-resistant coatings inspired by marine mussels.

Ko R, Cadieux PA, Dalsin JL, Lee BP, Elwood CN, Razvi H.

J Endourol. 2008 Jun;22(6):1153-60. doi: 10.1089/end.2008.0049.

PMID:
18484883
22.

Triclosan inhibits uropathogenic Escherichia coli-stimulated tumor necrosis factor-alpha secretion in T24 bladder cells in vitro.

Elwood CN, Chew BH, Seney S, Jass J, Denstedt JD, Cadieux PA.

J Endourol. 2007 Oct;21(10):1217-22.

PMID:
17949329
23.

In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens.

Chew BH, Cadieux PA, Reid G, Denstedt JD.

J Endourol. 2006 Nov;20(11):949-58.

PMID:
17144870
24.

Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.

Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, Chilcott CN, Reid G, Tagg JR.

Antonie Van Leeuwenhoek. 2006 Oct;90(3):269-80. Epub 2006 Jul 27.

PMID:
16871420
25.

Rat PSP94 inhibits the growth and viability of the rat adenocarcinoma cell line PAIII in vitro.

Cadieux PA, Mikolajczak SA, Reeves J, Strathdee C, Reid G, Panchal CJ, Clarke MW.

Cancer Invest. 2006 Apr-May;24(3):246-55.

PMID:
16809150
26.

Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.

Cadieux PA, Chew BH, Knudsen BE, Dejong K, Rowe E, Reid G, Denstedt JD.

J Urol. 2006 Jun;175(6):2331-5.

PMID:
16697868
27.

Urinary tract biomaterials.

Beiko DT, Knudsen BE, Watterson JD, Cadieux PA, Reid G, Denstedt JD.

J Urol. 2004 Jun;171(6 Pt 1):2438-44. Review.

PMID:
15126872
28.

Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis.

Cadieux PA, Beiko DT, Watterson JD, Burton JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF, Denstedt JD, Reid G.

J Clin Lab Anal. 2004;18(3):170-5.

PMID:
15103681
29.

Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation.

Burton JP, Devillard E, Cadieux PA, Hammond JA, Reid G.

J Clin Microbiol. 2004 Apr;42(4):1829-31.

30.

Swarming of Proteus mirabilis over ureteral stents: a comparative assessment.

Watterson JD, Cadieux PA, Stickler D, Reid G, Denstedt JD.

J Endourol. 2003 Sep;17(7):523-7.

PMID:
14565887
31.

Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation.

Watterson JD, Cadieux PA, Beiko DT, Cook AJ, Burton JP, Harbottle RR, Lee C, Rowe E, Sidhu H, Reid G, Denstedt JD.

J Endourol. 2003 Jun;17(5):269-74.

PMID:
12885351
32.
33.

Supplemental Content

Loading ...
Support Center